Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-25 05:56:56 - browse：391

Photograph of a person wearing blue gloves counts money. -- health business coverage from STAT — Adobe

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another.

Medicare officials last week announced its major annual update to the way the program pays physicians. Along with other changes, it includes a policy that will boost payments to specialties that rely on evaluating and managing patients, as opposed to those that focus on procedures. But in Medicare, boosting payments in one area almost always means cutting them somewhere else. So to pay for that, doctors across the country will see a roughly 3% cut to a factor that determines how much Medicare pays them for caring for seniors.

The change has pitted certain specialties against primary care doctors. A host of surgeons’ groups, including the American College of Surgeons, plainly criticized family physicians in a recent letter to Medicare, saying there’s no “valid justification” for the boost and calling it an “inappropriate” overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Boston competes with Raleigh

WSS

Scientists boost immune system in aging mice by making it youthful

States should stop sabotaging methadone treatment reform

Readout LOUD podcast: mifepristone case, GLP

Wegovy leads to weight loss. Can it treat depression, too?

Wegovy leads to weight loss. Can it treat depression, too?

Abortion pill Supreme Court ruling could impact entire drug industry

Wikipedia

Wikipedia

hotspot

Jerome Adams on the need for new antivirals for Covid

Covid vaccine financial winners and losers, from Pfizer to Novavax

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Supreme Court strikes down use of affirmative action

Medicare drug price negotiation legal challenge met with skepticism

What does generative AI mean for health care? We asked experts

Humana’s losses in Medicare Advantage tank its stock

Apple is now the first public company to be valued at $3 trillion

New clues to why women have higher risk of autoimmune disorders

hotspot

Scientists boost immune system in aging mice by making it youthful

10 reasons why health care startups fail

Covid vaccine financial winners and losers, from Pfizer to Novavax

Medicare Advantage insurers face 0.2% cut to 2025 payments

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Syphilis numbers in the United States reach record heights

knowledge

focus

hotspot

entertainment